Skip to main content

Emtricitabine and tenofovir disoproxil fumarate

NDC 82804-086 · Proficient Rx LP

Generic nameEmtricitabine and tenofovir disoproxil fumarate
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Strength200; 300 mg/1; mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
Marketing categoryANDA

Packages

82804-086-03 — 3 TABLET, FILM COATED in 1 BOTTLE (82804-086-03)

82804-086-07 — 7 TABLET, FILM COATED in 1 BOTTLE (82804-086-07)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69238-2095 — Emtricitabine and Tenofovir Disoproxil Fumarate, 70710-1364 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1365 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1366 — Emtricitabine and tenofovir disoproxil fumarate, 70710-1367 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1620 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1621 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1622 — Emtricitabine and tenofovir disoproxil fumarate, 70771-1709 — Emtricitabine and tenofovir disoproxil fumarate, 71205-776 — Emtricitabine and Tenofovir Disoproxil Fumarate, 71335-2364 — Tenofovir Disoproxil Fumarate, 71335-2650 — Emtricitabine and Tenofovir Disoproxil Fumarate, 71335-3155 — Tenofovir Disoproxil Fumarate, 71921-105 — Tenofovir Disoproxil Fumarate, 72162-2565 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 72189-312 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 72189-403 — Emtricitabine/TDF, 72789-361 — Tenofovir Disoproxil Fumarate, 76282-677 — EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, 82009-109 — Emtricitabine and Tenofovir Disoproxil Fumarate, +82 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels